However, genetic data does not predict exact thermoregulatory response or guarantee specific side effects
Potential Side Effects at 4 mg, 9 mg, and 12 mg TRANSCEND-T2D-1 reported nausea in 16.4%, 19.5%, and 26.5% of participants receiving 4 mg, 9 mg, and 12 mg, respectively, compared with 3.7% with placebo [9]
16 In this study, the use of GLP-1 receptor agonists was associated with a lower risk for an alcohol-related event (hazard ratio [HR], 0.46
Levels of free carnitine (CAR), calcium (Ca), inorganic phosphate (P), Ca x P product, parathormone (PTH), bone-specific alkaline phosphatase (b-ALP), osteocalcin (OC), and osteoprotegerin (OPG) were monitored
This is why two researchers can use the same vial, the same total volume, and get different results